Navigation Links
Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
Date:4/18/2013

ccination levels (i.e. levels considered protective in humans or "seroconverted") against the currently circulating H1N1 A/California/07/09 strain. This response rate was comparable to that seen in volunteers who received the matched seasonal influenza vaccine, where 6 of 10 (60%) seroconverted against H1N1 A/California/07/09.

"We couldn't be more pleased with the results from this proof-of-principle and dose-finding study of our H1N1 universal influenza vaccine," said Dr. J. Joseph Kim , Inovio's President and CEO. "We have already demonstrated that we can generate protective antibodies against the important H1N1 strains of the last century using our H1N1 universal vaccine. The new data shows that our universal approach can achieve protection rates comparable to the current seasonal vaccines, which require annual changes to try to match the predicted circulating strains. Collectively, these results further support our mission to develop a universal influenza vaccine capable of providing years of true preemptive protection across subtypes and strains. These results add significantly to the advancement of our seasonal universal flu vaccine program. They will also help fine-tune dosing for our pandemic avian H5N1 program and support our research for the new H7N9 subtype that has emerged even more rapidly than H5N1."

Inovio previously reported interim results from this phase I study showing that its SynCon® universal H1N1 influenza vaccine generated protective HAI titers against some of the most prevalent strains of H1N1 influenza from the past 100 years. The vaccine recipients from this study generated protective HAI responses against the H1N1 A/South Carolina/1/18 strain (so-called 1918 Spanish flu) as well as all the H1N1 strains that were part of the seasonal trivalent inactivated flu vaccines (TIV) since 1986, including: A/Taiw
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW ... for operable and inoperable solid tumor cancers, announced today that ... th Annual Phacilitate Immunotherapy Forum in Washington ... will take place on January 26 at 10:30 a.m. EST ...
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... announces that a new market research report is available ... http://www.reportlinker.com/p0357031/Regenerative-Medicine-Markets.html Regenerative ... human tissue by using laboratory-grown or therapeutically-induced human tissue ... the ability to repair or replace damaged human tissue ...
... YORK, Dec. 29, 2010 Reportlinker.com announces that ... its catalogue: 2010-2015 In-depth Research ... http://www.reportlinker.com/p0356862/2010-2015-In-depth-Research-Report-on-China-Sodium-Fluoride-Industry.html Report ... State Statistical Bureau, General Administration of Custom, Ministry ...
Cached Medicine Technology:Reportlinker Adds Regenerative Medicine Markets 2Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... cut bleeding time in half, but use in humans is ... Hoping to improve on nature, researchers have built and tested ... used in trauma or other cases where blood just won,t ... material that is used in degradable stitches, which dissolve in ...
... determining factor for use, expert says, , WEDNESDAY, Dec. 16 ... less likely to die when they receive an implantable cardioverter ... people, ages 65 to 85, who were eligible for the ... the heart,s pumping ability) of 35 percent or less. , ...
... Dec. 16 Medical travel facilitator Companion Global Healthcare ... into its network of international hospitals that treat American ... U.S. facilities. , The announcement means Companion Global Healthcare ... its individual clients and employer group members who seek ...
... FRANCISCO, Dec. 16 Quantros, Inc., a leading provider ... for the healthcare industry, announces the creation of a ... industry veteran Michael Tulloch, MBA, as Director of IT ... Marlborough, MA office. , "The expansion into IT services ...
... happens when the families of sick and dying hospitalized children ... How do pediatricians respond to such personal requests? While increasing ... patients and families cope with serious illness, a new study ... who raise the issue of prayer, not the doctors themselves. ...
... Dec. 16 Tyco International Ltd. (NYSE: TYC ... election to the Tyco Board of Directors at the company,s ... 55, is Senior Vice President of the Global Technology Services ... has worldwide responsibility for IBM,s Global Services business operations consisting ...
Cached Medicine News:Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:Implanted Defibrillator Might Extend Life 2Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Prayer on the hospital floor 2Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2
Midstream Catch Kits...
... is a portable, noninvasive ultrasound instrument that ... to use, and quickly provides accurate results. ... use the BladderScan® to obtain a precise ... BladderScan® supplies the information that caregivers need ...
... Mobile BladderScan® BVI 6400 calculates bladder ... technology. V-MODE® ultrasound is accurate, fast, ... the BladderScan® measures ultrasonic reflections within ... creates a 3-dimensional image of the ...
... The Titan™ Inflatable Penile Prosthesis ... designed to be surgically implanted ... management of erectile dysfunction (also ... provides the patient with voluntary ...
Medicine Products: